Oruka Therapeutics (ORKA) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.87% |
| Dec 31, 2025 | -73.32% |
| Sep 30, 2025 | -46.68% |
| Jun 30, 2025 | -97.10% |
| Mar 31, 2025 | -148.65% |
| Dec 31, 2024 | -114.03% |
| Sep 30, 2024 | -110.99% |
| Jun 30, 2024 | -27.27% |
| Mar 31, 2024 | -35.00% |
| Dec 31, 2023 | -41.46% |
| Sep 30, 2023 | -36.65% |
| Jun 30, 2023 | -33.04% |
| Mar 31, 2023 | -27.56% |
| Dec 31, 2022 | -29.28% |
| Sep 30, 2022 | -22.47% |
| Jun 30, 2022 | -23.74% |
| Mar 31, 2022 | -20.62% |
| Dec 31, 2021 | -20.32% |
| Sep 30, 2021 | -19.97% |
| Jun 30, 2021 | -19.11% |
| Mar 31, 2021 | -16.92% |
| Dec 31, 2020 | -4.81% |
| Sep 30, 2020 | -4.26% |
| Jun 30, 2020 | 24.19% |
| Mar 31, 2020 | 11.34% |
| Dec 31, 2019 | 11.44% |
| Sep 30, 2019 | 10.98% |
| Jun 30, 2019 | 12.45% |
| Mar 31, 2019 | 17.70% |
| Dec 31, 2018 | 16.98% |
| Sep 30, 2018 | 15.39% |
| Jun 30, 2018 | 13.91% |
| Mar 31, 2018 | -27.88% |
| Dec 31, 2017 | -32.11% |
| Sep 30, 2017 | -38.94% |
| Jun 30, 2017 | -38.14% |
| Mar 31, 2017 | -35.36% |
| Dec 31, 2016 | -28.92% |
| Sep 30, 2016 | -32.49% |
| Jun 30, 2016 | -28.71% |
| Mar 31, 2016 | -43.21% |
| Dec 31, 2015 | -40.75% |
| Sep 30, 2015 | -39.31% |
| Jun 30, 2015 | -34.77% |